E-LIB Suche - Ergebnisse für: Gates, Mary R.

1

Optimizing Early-stage Clinical Pharmacology Evaluation to ..:

Malhi, Vikram ; Agarwal, Priya ; Gates, Mary R....
Cancer Research Communications. 3 (2023) 12 - p. 2551-2559 , 2023

2

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Lutein..:

Jhaveri, Komal L. ; Bellet, Meritxell ; Turner, Nicholas C....
Clinical Cancer Research. 30 (2023) 4 - p. 754-766 , 2023

Link: https://doi.org/10.1158/..

3

Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) ..:

Shapiro, Geoffrey I. ; LoRusso, Patricia ; Kwak, Eunice...
Investigational New Drugs. 38 (2019) 2 - p. 419-432 , 2019

Link: https://doi.org/10.1007/..

4

[3H]N-2-(4-(N-Benzamido)phenyl)propyl-2- propanesulfonamide..:

Zarrinmayeh, Hamideh ; Bleakman, David ; Gates, Mary R....
Journal of Medicinal Chemistry. 44 (2001) 3 - p. 302-304 , 2001

Link: https://doi.org/10.1021/..

5

The novel atypical antipsychotic olanzapine, but not the CC..:

Rasmussen, Kurt ; Gates, Mary R ; Burger, James E.
Neuroscience Letters. 222 (1997) 1 - p. 61-64 , 1997

Link: https://doi.org/10.1016/..

6

A Reconsideration of Bilateral Language Representation Base..:

Risse, Gail L. ; Gates, John R. ; Fangman, Mary C.
Brain and Cognition. 33 (1997) 1 - p. 118-132 , 1997

Link: https://doi.org/10.1006/..

7

Erratum: correction: Kainate receptors are involved in syna..:

Bortolotto, Zuner A. ; Clarke, Vernon R. J. ; Delany, Caroline M....
Nature. 409 (2001) 6819 - p. 542-542 , 2001

Link: https://doi.org/10.1038/..

8

Biarylpropylsulfonamides as Novel, Potent Potentiators of 2..:

Ornstein, Paul L. ; Zimmerman, Dennis M. ; Arnold, M. Brian...
Journal of Medicinal Chemistry. 43 (2000) 23 - p. 4354-4358 , 2000

Link: https://doi.org/10.1021/..

9

Kainate receptors are involved in synaptic plasticity:

Bortolotto, Zuner A. ; Clarke, Vernon R. J. ; Delany, Caroline M....
Nature. 402 (1999) 6759 - p. 297-301 , 1999

Link: https://doi.org/10.1038/..

10

Letters to the editor:

Gates, R. Patrick ; Arnold, Connie ; Cooke, Mary A....
American Journal of Hospice and Palliative Medicine®. 10 (1993) 4 - p. 3-3 , 1993

Link: https://doi.org/10.1177/..

11

Supplementary Figure S3 from Phase Ia/b Study of Giredestra..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232186.v1. , 2024

Link: https://doi.org/10.1158/..

12

Supplementary Table S4 from Phase Ia/b Study of Giredestran..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232174.v1. , 2024

Link: https://doi.org/10.1158/..

13

Supplementary Table S1 from Phase Ia/b Study of Giredestran..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232183.v1. , 2024

Link: https://doi.org/10.1158/..

14

Supplementary Figure S2 from Phase Ia/b Study of Giredestra..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232189.v1. , 2024

Link: https://doi.org/10.1158/..

15

Supplementary Figure S1 from Phase Ia/b Study of Giredestra..:

Komal L. Jhaveri ; Meritxell Bellet ; Nicholas C. Turner...
doi:10.1158/1078-0432.25232192.v1. , 2024

Link: https://doi.org/10.1158/..